Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 99 INDUSTRY 34 OTHER_GOV 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Specimen Handling 40 Magnetic Resonance Spectroscopy 30 Carboplatin 14 Biopsy 14 Radiation 13 Cyclophosphamide 13 Radiotherapy 11 daratumumab 10 Vincristine 10 Dexamethasone 10 Surgical Procedures, Operative 9 Etoposide 9 Lenalidomide 8 X-Rays 7 Observation 7 Leucovorin 7 Irinotecan 7 Doxorubicin 7 Cisplatin 7 durvalumab 6 dexamethasone acetate 6 dexamethasone 21-phosphate 6 auricularum 6 Watchful Waiting 6 Standard of Care 6 Radiosurgery 6 Practice Guidelines as Topic 6 Docetaxel 6 Calcium Dobesilate 6 pembrolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × toripalimab × Clear all

NCT04918186 2026-05-12

IPROC

Canadian Cancer Trials Group

Phase 2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡